What Is the Life Expectancy of Someone With an Aortic Aneurysm?

Life expectancy with an aortic aneurysm varies so widely that a single number would be misleading. A small abdominal aortic aneurysm that sits below the surgical threshold and stays under surveillance can coexist with a near-normal lifespan. A large, rapidly growing aneurysm that ruptures before it can be repaired is among the most lethal emergencies in medicine. Between those extremes, outcomes depend on aneurysm size, location, growth rate, sex, overall cardiovascular health, and whether you eventually undergo elective repair.

Size Drives Nearly Everything

The diameter of the aneurysm is the strongest predictor of what happens next. For abdominal aortic aneurysms (AAA), current guidelines recommend repair once the diameter reaches about 5.5 cm in men or about 5.0 cm in women. Below those thresholds, rupture risk is low enough that watchful waiting with periodic imaging is the standard approach. One long-term study found that the cumulative rupture rate for small aneurysms under 5 cm was just 2.5% over seven years, and no aneurysm could be confirmed to have ruptured while still smaller than 5 cm.¹ That same study reported overall five-year survival of about 51% across all patients, but the population included many elderly people with serious cardiovascular disease, and aneurysm rupture was not the main cause of death for those with smaller aneurysms.

Once aneurysms grow past the repair threshold, the numbers shift fast. The annual rupture risk for men with AAAs of 5.0 to 5.9 cm is roughly 1%, but for men with aneurysms 6 cm or larger, it jumps to about 14% per year. In women, those same size categories carry rupture risks of roughly 4% and 22% per year, respectively.² A separate study of patients whose large AAAs went unrepaired found that the three-year cumulative incidence of rupture ranged from about 2% for aneurysms of 5.5 to 6.0 cm up to roughly 18% for those over 7 cm.³

Thoracic aortic aneurysms follow a similar pattern, though with their own numbers. A population-based study found that the five-year cumulative probability of rupture for thoracic aneurysms was about 20%.⁴ In untreated thoracic aneurysms, each additional centimeter of diameter was associated with roughly double the risk of death, and growth rate independently doubled the risk as well.⁵ The key factors that push any aneurysm toward rupture include size, expansion rate, continued smoking, and persistent high blood pressure.⁶

What Happens When an Aneurysm Ruptures

Rupture is the scenario everyone fears, and the statistics bear out that fear. A large meta-analysis estimated the total mortality rate from ruptured abdominal aortic aneurysms at roughly 81%, though it has improved somewhat over time, dropping from about 86% in studies before 1990 to around 74% in more recent data.⁷ About a third of patients with a ruptured AAA die before reaching the hospital. Of those who do make it to surgery, survival depends heavily on their condition at arrival. A study of 125 emergency repair patients found that in-hospital mortality was 42% overall, but the presence of factors like advanced age, kidney disease, loss of consciousness, cardiac arrest, or shock pushed mortality progressively upward, from 11% with none of those factors to 89% when four were present.⁸

Thoracic aneurysm rupture is even more dire. An older study found that over 97% of patients with ruptured thoracic aneurysms died, with more than half dying outside the hospital and 54% dying within six hours of symptom onset.⁹ Acute type A aortic dissection, a related catastrophe in which the inner wall of the aorta tears, carries similarly brutal early mortality. Without surgery, roughly 24% of patients die within 48 hours. With emergency surgical repair, that number drops to about 4% at 48 hours.¹⁰ Among those who survive emergency dissection surgery, longer-term outcomes are more encouraging: about 73% survive the first year, roughly 68% reach five years, and around 54% are alive at ten years.¹¹

How Elective Repair Changes the Outlook

Elective surgery, performed before rupture, dramatically improves the picture. The goal is to replace or reinforce the weakened section of the aorta before disaster strikes. Two approaches are used: traditional open surgical repair and the less invasive endovascular approach, where a stent graft is threaded through the groin artery and deployed inside the aneurysm.

For abdominal aneurysms, these two methods produce roughly similar long-term survival. A major randomized trial followed patients for over a decade and found that about 68 to 70% of patients in both groups were alive at six years, with no significant survival difference between the approaches.¹² A longer-term trial with up to 15 years of follow-up confirmed this, finding no lasting survival advantage for either technique, though the relative performance seemed to shift slightly back and forth over different time periods.¹³ One large observational study using matched Medicare data did find that open repair was associated with lower long-term mortality and fewer late ruptures and reinterventions.¹⁴ The tension between the two methods is real: endovascular repair is easier to recover from initially but tends to require more follow-up procedures, while open repair is a bigger operation upfront but may last longer without needing a redo.

For thoracic aneurysms in the descending aorta, endovascular repair has a significant early survival advantage. Six-month mortality was about 10% for endovascular repair compared with roughly 24% for open surgery, with the gap even wider at lower-volume hospitals. Over the longer term, however, open repair carried a slightly lower ongoing hazard of death, suggesting the stent grafts may develop problems that accumulate over time.¹⁵

Why Women Face Higher Rupture Risk

Women develop aortic aneurysms less frequently than men, but when they do, the outcomes tend to be worse. A large study of untreated AAA patients found that within five years, about 10% of women experienced rupture compared with about 7% of men. Female sex independently predicted higher rupture risk even after adjusting for other variables. After five years, more than half of both groups had died, though the leading causes of death were heart disease and cancer, not rupture.¹⁶ For thoracic aneurysms, the sex disparity is striking: one study reported that the five-year probability of rupture was 33% for women and 9% for men, and women accounted for 79% of all ruptures.⁴

Part of the reason is anatomical: women have smaller aortas to begin with, so an aneurysm at the same absolute diameter represents a proportionally larger distension. This is why guidelines recommend a lower threshold for surgical repair in women. When it comes to surgical results, women had higher 30-day mortality after open repair of both intact and ruptured aneurysms. However, when treated with endovascular repair, 30-day mortality was similar for men and women, and after adjusting for age and other risk factors, sex alone did not independently predict death.¹⁷

Medications That Can Tip the Scales

No drug has been proven to reliably shrink an aortic aneurysm or prevent one from forming. However, several medications affect either the growth rate or the survival odds after repair. Statins, the cholesterol-lowering drugs, show the most promising signal. A meta-analysis found that statin use was associated with a roughly 43% lower rate of long-term mortality after AAA repair.¹⁸ A separate analysis found that patients on statins had higher survival at both one year and five years after surgery, with the largest absolute benefit seen in patients who had undergone repair for a ruptured aneurysm.¹⁹ Statins also appear to modestly slow aneurysm growth by roughly a third of a millimeter per year, according to a recent meta-analysis.²⁰ That effect is small in absolute terms but could meaningfully delay the date an aneurysm reaches the repair threshold.

Blood pressure medications and beta-blockers, despite seeming like obvious candidates, have been disappointing. A systematic review and meta-analysis of blood pressure-lowering drugs found they did not reduce AAA growth or aneurysm-related events.²¹ Beta-blockers specifically showed no statistically significant effect on aneurysm growth across eight clinical trials.²² That doesn’t mean controlling blood pressure is pointless for someone with an aneurysm; high blood pressure contributes to cardiovascular death from all causes, and these patients are at elevated risk of heart attack and stroke. But the drugs don’t appear to slow the aneurysm itself.

Smoking Cessation and Exercise

Smoking is the single strongest modifiable risk factor for developing an AAA and for making an existing one grow faster. While direct proof from clinical trials is thin, a network meta-analysis found that quitting smoking seems to reduce AAA growth rate to levels similar to people who never smoked.²³ Health-economic modeling suggests smoking cessation would be a cost-effective strategy, and it remains a priority recommendation for every patient with an aneurysm.²⁴

Physical activity is another area where people with aneurysms often feel uncertain. For those with small, pre-surgical aneurysms, exercise appears safe and can improve cardiovascular fitness. A meta-analysis of randomized trials found the cardiovascular event rate during exercise testing and training was under 1%, and exercise did not tend to increase aneurysm diameter.²⁵ Moderate exercise programs improved cardiovascular capacity and showed potential anti-inflammatory effects.²⁶ Whether exercise directly slows aneurysm growth remains unclear, and the evidence applies only to aneurysms under 5.5 cm, since no trials have enrolled patients with larger ones.²⁷

Life After Repair

Surviving surgery is one milestone, but patients understandably want to know what life looks like afterward. Quality-of-life research shows that both open and endovascular repair cause a dip in physical and mental well-being in the weeks after surgery, but most patients return to their baseline within a few months. After endovascular repair, mental health scores tend to recover by about four to six weeks, while physical health takes up to three months.²⁸ Patients in their 80s take longer to bounce back and may not fully recover their quality of life within the first year.²⁹

Long-term surveillance is an unavoidable part of endovascular repair. Stent grafts can develop leaks, migrate, or develop other complications that occasionally require a second procedure. One study found that freedom from reintervention was about 73% at five years, though aneurysm-related survival remained high: roughly 98% at five years and 95% at ten years for patients who did not need a second procedure.³⁰ Reassuringly, the most common type of stent leak, called a type II endoleak, appears benign and is not associated with long-term mortality.³¹ Still, the need for regular imaging follow-up is a trade-off that patients should factor in when discussing their options with a surgeon.

Screening and How It Changes the Odds

Because aortic aneurysms grow silently for years before causing symptoms, screening can catch them at a stage where elective repair is still an option. In the United States, the USPSTF recommends a one-time abdominal ultrasound for men aged 65 to 75 who have ever smoked. The evidence behind that recommendation is strong: a meta-analysis of large randomized trials estimated that screening invitations to men 65 or older cut AAA-related deaths by about 35% over 12 to 15 years and reduced emergency surgeries by roughly 43%.³² The UK’s national screening program has reported a 48% relative reduction in AAA-related deaths over ten years compared with unscreened controls.³³

It is worth noting that while screening saves lives from aneurysm rupture, it has not shown a clear effect on all-cause mortality. That is because most people with aneurysms are older adults with significant cardiovascular disease, and many die of heart attacks, strokes, or cancer whether or not their aneurysm is detected.³² Screening also remains less well-established for women and for thoracic aneurysms, where guidelines are less definitive. The UK screening program focuses on men aged 65 and has continued to demonstrate long-term benefits in that population.³⁴

Connective Tissue Disorders and Younger Patients

Most aortic aneurysms develop in older adults as a result of atherosclerosis, but genetic connective tissue disorders like Marfan syndrome cause aneurysms in much younger people. The prognosis for these patients has improved dramatically. In the mid-1990s, researchers reported that the median cumulative survival for Marfan syndrome patients who underwent aortic aneurysm repair had risen to 61 years, up from a median of 47 years measured three decades earlier.³⁵ That improvement reflects better surgical technique, more proactive screening, and medical management with drugs that reduce aortic wall stress. However, over half of patients in that study needed additional surgery for new aneurysms or dissections at other points along the aorta, underscoring that these patients require lifelong surveillance.

Other heritable conditions, including Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, and bicuspid aortic valve disease, also carry elevated aneurysm risk. The specifics vary, but the general principle holds: early detection and planned repair yield far better outcomes than emergency intervention, and these patients often need surgery at smaller aneurysm diameters than the general population.

Moving Beyond Diameter Alone

The current clinical rule of “repair at 5.5 cm” is a pragmatic threshold, not a perfect one. Estimates suggest that up to a quarter of AAAs that rupture are still smaller than 5.5 cm at the time.³⁶ Conversely, many large aneurysms never rupture. Diameter alone misses the mechanical picture: how much stress the wall is under, how thick or thin the wall is at different points, and how blood flow dynamics shape the forces on the weakest spots.

Researchers are developing artificial intelligence tools to make rupture prediction more personalized. One machine learning model trained on patient data achieved strong accuracy in distinguishing stable aneurysms from those that would require intervention or rupture, with performance metrics above 0.80 across categories on validation testing.³⁷ Separate work using neural networks to simulate fluid and wall interactions in thoracic aneurysms has shown promising accuracy for estimating rupture risk from patient-specific anatomy.³⁸ None of these tools have replaced the diameter threshold in clinical practice yet, but they represent a push toward tailoring decisions to individual patients rather than relying on a single measurement.

For patients with small aneurysms below the surgical threshold, this gap in clinical tools is frustrating. No approved pharmacological treatment exists specifically to prevent small aneurysms from growing to the point of needing surgery.³⁹ The management strategy is monitoring, risk factor control, and waiting, which can feel passive. But given the low rupture rates at small sizes, the evidence supports that patience over premature intervention. The challenge ahead is figuring out which of those small aneurysms are quietly dangerous and which ones will never cause trouble.